Cognition Therapeutics Inc (CGTX)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-01-31 | B Purchase |
CEO & President Executive Director |
38,851
+inf%
0.77USD 30,001 |
38,851 +inf% | 0.77 | USD 30,001 | |
| 2024-03-14 | 2024-03-14 | B Purchase |
CEO & President Executive Director |
5,700
+2.0%
1.75USD 9,975 |
5,700 +2.0% | 1.75 | USD 9,975 | |
| 2022-11-29 | 2022-11-29 | B Purchase | Non-Executive Director |
10,000
+inf%
2.66USD 26,550 |
10,000 +inf% | 2.66 | USD 26,550 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director Large shareholder |
1,871
+0.6%
2.65USD 4,958 |
1,871 +0.6% | 2.65 | USD 4,958 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director Large shareholder |
12,220
+0.6%
2.65USD 32,379 |
12,220 +0.6% | 2.65 | USD 32,379 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director Large shareholder |
1,973
+0.6%
2.65USD 5,228 |
1,973 +0.6% | 2.65 | USD 5,228 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director Large shareholder |
1,871
+0.6%
2.65USD 4,958 |
1,871 +0.6% | 2.65 | USD 4,958 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director Large shareholder |
12,220
+0.6%
2.65USD 32,379 |
12,220 +0.6% | 2.65 | USD 32,379 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director Large shareholder |
1,973
+0.6%
2.65USD 5,228 |
1,973 +0.6% | 2.65 | USD 5,228 | |
| 2022-11-17 | 2022-11-16 | B Purchase | Non-Executive Director |
8,269
+2.8%
1.40USD 11,577 |
8,269 +2.8% | 1.40 | USD 11,577 | |
| 2022-11-17 | 2022-11-16 | B Purchase | Non-Executive Director |
54,009
+2.8%
1.40USD 75,613 |
54,009 +2.8% | 1.40 | USD 75,613 | |
| 2022-11-17 | 2022-11-16 | B Purchase | Non-Executive Director |
8,722
+2.8%
1.40USD 12,211 |
8,722 +2.8% | 1.40 | USD 12,211 | |
| 2022-11-17 | 2022-11-16 | B Purchase | Non-Executive Director |
8,269
+2.8%
1.40USD 11,577 |
8,269 +2.8% | 1.40 | USD 11,577 | |
| 2022-11-17 | 2022-11-16 | B Purchase | Non-Executive Director |
54,009
+2.8%
1.40USD 75,613 |
54,009 +2.8% | 1.40 | USD 75,613 | |
| 2022-11-17 | 2022-11-16 | B Purchase | Non-Executive Director |
8,722
+2.8%
1.40USD 12,211 |
8,722 +2.8% | 1.40 | USD 12,211 | |
| 2022-11-16 | 2022-11-15 | B Purchase |
CEO & President Executive Director |
12,000
+96.0%
1.30USD 15,600 |
12,000 +96.0% | 1.30 | USD 15,600 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Non-Executive Director |
174,700
+139.9%
1.20USD 209,640 |
174,700 +139.9% | 1.20 | USD 209,640 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Non-Executive Director |
1,141,030
+140.1%
1.20USD 1,369,236 |
1,141,030 +140.1% | 1.20 | USD 1,369,236 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Non-Executive Director |
184,270
+139.8%
1.20USD 221,124 |
184,270 +139.8% | 1.20 | USD 221,124 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Non-Executive Director |
174,700
+139.9%
1.20USD 209,640 |
174,700 +139.9% | 1.20 | USD 209,640 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Non-Executive Director |
1,141,030
+140.1%
1.20USD 1,369,236 |
1,141,030 +140.1% | 1.20 | USD 1,369,236 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Non-Executive Director |
184,270
+139.8%
1.20USD 221,124 |
184,270 +139.8% | 1.20 | USD 221,124 | |
| 2022-11-16 | 2022-11-15 | B Purchase | Non-Executive Director |
12,500
+49.1%
1.20USD 15,000 |
12,500 +49.1% | 1.20 | USD 15,000 | |
| 2021-10-25 | 2021-10-13 | B Purchase | Non-Executive Director |
3,000
+inf%
12.00USD 36,000 |
3,000 +inf% | 12.00 | USD 36,000 | |
| 2021-10-15 | 2021-10-13 | S Sale | Large shareholder |
74
-0.0%
12.00USD 889 |
74 -0.0% | 12.00 | USD 889 | |
| 2021-10-15 | 2021-10-13 | S Sale |
Golden Seeds Cognition Therapeutics LLC Large shareholder |
33
-0.0%
12.00USD 397 |
33 -0.0% | 12.00 | USD 397 | |
| 2021-10-15 | 2021-10-13 | B Purchase | Large shareholder |
144,530
+19.1%
12.00USD 1,734,360 |
144,530 +19.1% | 12.00 | USD 1,734,360 | |
| 2021-10-15 | 2021-10-13 | B Purchase | Large shareholder |
22,129
+33.6%
12.00USD 265,548 |
22,129 +33.6% | 12.00 | USD 265,548 | |
| 2021-10-15 | 2021-10-13 | S Sale | Large shareholder |
90
-0.0%
12.00USD 1,083 |
90 -0.0% | 12.00 | USD 1,083 | |
| 2021-10-15 | 2021-10-13 | B Purchase | Large shareholder |
23,341
+68.2%
12.00USD 280,092 |
23,341 +68.2% | 12.00 | USD 280,092 | |
| 2021-10-15 | 2021-10-13 | S Sale | Non-Executive Director |
12
-0.0%
12.00USD 141 |
12 -0.0% | 12.00 | USD 141 | |
| 2021-10-15 | 2021-10-13 | B Purchase | Non-Executive Director |
144,530
+19.1%
12.00USD 1,734,360 |
144,530 +19.1% | 12.00 | USD 1,734,360 | |
| 2021-10-15 | 2021-10-13 | B Purchase | Non-Executive Director |
22,129
+33.6%
12.00USD 265,548 |
22,129 +33.6% | 12.00 | USD 265,548 | |
| 2021-10-15 | 2021-10-13 | S Sale | Non-Executive Director |
90
-0.0%
12.00USD 1,083 |
90 -0.0% | 12.00 | USD 1,083 | |
| 2021-10-15 | 2021-10-13 | B Purchase | Non-Executive Director |
23,341
+68.2%
12.00USD 280,092 |
23,341 +68.2% | 12.00 | USD 280,092 | |
| 2021-10-14 | 2021-10-13 | B Purchase |
Chief Financial Officer Officer |
5,000
+inf%
12.00USD 60,000 |
5,000 +inf% | 12.00 | USD 60,000 | |
| 2021-10-14 | 2021-10-13 | B Purchase |
CEO & President Executive Director |
12,500
+inf%
12.00USD 150,000 |
12,500 +inf% | 12.00 | USD 150,000 |